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Abstract 
Problem: The U.S. Pharmacopeia (USP, 2016) Convention Chapter 800: Hazardous Drugs: 
Handling in Healthcare Settings took effect on December 1, 2019. According to Polovich and 
Olsen (2017), “The implementation of the USP <800> Standards will represent an important step 
forward to protect nurses and other potentially exposed health care workers (HCWs)” (p. 1). 
Context: The Doctor of Nursing Practice (DNP) project implemented a hazardous drug (HD) 
safe-handling personal protective equipment (PPE) toolkit in accordance to USP<800> standards 
and hospital policies at an ambulatory cancer infusion center to improve nurses’ adherence with 
PPE use. 
Interventions: The project consisted of (a) a safe-handling PPE toolkit, (b) a PPE observation 
tool, (c) an expert panel discussion, (d) a nurses’ skills session, (e) an online safe-handling 
survey, (f) an HD safe-handling checklist, and (g) a performance dashboard.  
Measures: Outcome measures included (a) 90% or higher compliance rate with PPE use during 
HD administration and (b) sustained adherence to USP <800> standards and hospital policies by 
February 2020. 
Results: A 90% compliance rate for PPE use during HD administration was achieved by 
February 2020. Sustainability is at risk due to the COVID-19 pandemic and global PPE shortage; 
however, nurses were able to adapt to new processes to conserve vital resources. 
Conclusions: A systems-thinking approach to the implementation of USP <800> standards for 
HD safe handling was successful in improving compliance and adherence to PPE use among 
ambulatory infusion nurses.  
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Section II: Introduction 
Problem Description 
In 2016, the National Institute for Occupational Safety and Health (NIOSH) reported 
more than eight million healthcare workers (HCWs) in the United States are potentially exposed 
to hazardous drugs (HDs). HCWs with long-term, low-level occupational exposure have shown 
an increased risk of adverse reproductive outcomes and other life-threatening health issues 
(Connor et al., 2014; Hon et al., 2014). Adverse health outcomes include genetic changes, cancer 
development, congenital disabilities and fetal abnormalities, organ toxicity, and infertility, 
among others. McDiarmid and Condon (2005) reported a 20% increase in chromosomal 
abnormalities in exposed HCWs who had a moderate level of HD handling (>100 handling 
events of chemotherapy within six weeks). Lack of dynamic organization and worker 
accountabilities and poor oversight of HD handling resulting in environmental contamination 
have caused irreversible harm and death in some cases (Smith, 2010). 
Healthcare organizations have prepared for the implementation of the USP Chapter 800: 
Hazardous Drugs-Handling in Health Care Settings (USP <800>) since 2016, whereby stricter 
regulatory standards provide enforceable safe-handling protections for all HCWs to minimize the 
risk of HD exposure (U.S. Pharmacopeial Convent [USP], 2016). As USP <800> preparations 
evolve, enhanced organizational efforts to educate staff and enforce compliance measures are 
driving new worker safety practices across health systems in the United States (Andrews & Dill, 
2018). Despite scientific evidence of known exposures and adverse health outcomes to HCWs, 
resistance to personal protective equipment (PPE) use during HD handling continues.   
Researchers from NIOSH and the Harvard T. H. Chan School of Public Health, Harvard 
Medical School, and Brigham and Women’s Hospital in Boston, Massachusetts, reported survey 
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data from 40,000 American and Canadian nurses, ages 29 to 49 years, who participated in the 
Nurses’ Health Study 3 since 2010 (Burdick, 2019). Researchers reported that 12% of non-
pregnant nurses and 9% of pregnant nurses indicated they did not wear gloves when 
administering antineoplastic drugs. Forty-two percent of non-pregnant nurses and 38% of 
pregnant nurses did not use a gown. About one in 10 nurses during their first 20 weeks of 
pregnancy did not always wear gloves, and one in two did not always wear a protective gown 
when administering HDs. According to Hennessy and Dynan (2014), “Resistance is based on a 
denial of risk, insufficient information, lack of policy enforcement or regulation, or lack of 
provision of safe-handling devices” (p. 497). Sadly, toxic HD residues found on healthcare 
surfaces have now infiltrated the home surfaces of treated patients, exposing cohabitants, family 
pets, and the community environment (Bohlandt et al., 2017; Connor et al., 2016; Yuki et al., 
2013). 
Ambulatory care infusion nurses have not fully adopted policy efforts that changed PPE 
use from guidelines to mandatory requirements through the implementation of USP <800>. The 
primary reason for implementing this evidence-based practice (EBP) initiative was two-fold: (a) 
USP <800> requires HCWs to wear PPE when handling HDs, and (b) HD policies must be 
strictly followed to meet USP <800> standards to improve HCW safety. The quality 
improvement (QI) intervention’s aim is to ensure that infusion nurses are prepared to follow the 
new USP <800> standards and to provide a PPE resource toolkit to improve HCW safety.  
The project took place in an ambulatory infusion center (AIC) setting. The AIC has 36 
infusion treatment chairs utilized primarily by oncology patients receiving intravenous (IV) 
chemotherapy. However, patients may also receive chemotherapy for non-oncologic health 
problems. The study involved the observation of experienced infusion nurses, defined as having 
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two or more years in HD administration, to determine the baseline adherence rate of PPE use 
with HD handling after nurses completed an online self-assessment survey. All nurses carry a 
chemotherapy and biotherapy certification card that indicates sufficient training and competence 
in the area of HD administration and drug knowledge. The first goal was to have 100% of the 
surveys returned and to observe at least 90% of the nurses prepare, administer, and dispose of 
HDs over four weeks. Ten nurses were eligible to participate in the QI project. Since policies 
specific to PPE requirements with HD handling were being revised by the organization, approval 
was given to use the most current HD policy until the 2020 policies became available. 
Available Knowledge 
PICOT Question 
The following PICOT question was formulated to guide a literature search for evidence-
based solutions: Would the development of an HD safe-handling PPE toolkit improve infusion 
nurses’ compliance and adherence with PPE use during HD handling and improve compliance 
with USP <800> standards and hospital policies for HD handling by February 1, 2020?  
Literature Review 
The Doctor of Nursing Practice (DNP) student conducted a literature review using 
CINAHL (Cumulative Index to Nursing and Allied Health), Cochrane Library, and PubMed 
databases to locate information on recommendations to improve PPE use in nurses. More than 50 
studies and articles from 2015 to 2019 were located in the search, with 15 selected for further 
review (see Appendix A). Findings demonstrated a clear and present danger regarding HD 
exposure and the need to consider mandatory EBP interventions and environmental oversight in 
the workplace. Excluded articles were those that focused on hospital HD administration, routes 
of administration of HDs other than IV, anesthesia HDs, and occupations outside the healthcare 
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setting. Keywords for the search included hazardous drugs, occupational health, protective 
equipment, safety standards, and USP <800>.   
Final literature selection criteria were determined after analyzing the strengths, 
weaknesses, limitations, and quality of evidence using the Johns Hopkins Nursing Evidence-
Based Practice Tool (Dearholt & Dang, 2016). There were five Level 1A, four Level IIA, and six 
Level IIIA quality ratings for the selected articles, which represents a quality approach for 
selecting evidence to address the problem. The articles and research studies identified three 
themes: (a) HD residues found in patient homes after treatment, (b) organizational safety culture 
responsibilities, and (c) nurses’ attitudes and behaviors toward PPE use must change from 
complacency to corrective action for personal and public safety. 
Summary of Evidence 
First, there is no safe level of HD exposure reported in the literature by the experts.  
Several research studies shed light on the issues surrounding involuntary HD exposure. One 
study, presented by Yuki et al. (2013), tested the urine of family members of three cancer 
patients who received at least one of two antineoplastic drugs (cyclophosphamide [CP] and 
fluorouracil [5-FU]) during the first 48 hours after chemotherapy treatment and found detectable 
levels of CP exposure. Swipe tests of common household surfaces showed contamination of HD 
residues inside the homes, confirming that low-level exposure is possible and must be further 
studied. 
Bohlandt et al. (2017) conducted an environmental and biological study inside 13 homes 
of treated cancer patients and confirmed HD residues on household surfaces. The researchers 
obtained 265 swipe samples in the homes and found that toilets, floor and sink handles, and 
kitchen surfaces had measurable levels of HD residues left behind by treated patients. Crickman 
USP <800> AND THE PPE PROJECT   11 
 
and Finnell’s (2016) systematic literature review determined that HCWs were at high risk of 
exposure, which included caregivers who were not responsible for medication administration but 
cleaned up after a treated patient. The main concern was about family member exposure risks 
because they often become the primary caregivers after chemotherapy treatments. PPE selection, 
HCW competencies, increased oversight, and medical monitoring of high-risk personnel were 
highlighted as critical strategies to prevent and manage involuntary exposure in the work 
environment. 
Clark et al. (2014) developed a field study investigating the influence of role definitions 
on the association between safety climate and employees’ organizational citizenship behavior. 
Providing safe working conditions requires a significant commitment on the part of leadership 
and stakeholders. Unfortunately, an organization’s obligation to provide safe working conditions 
can be overshadowed by conflicting priorities and budgetary constraints. However, Clark et al. 
stated that nurses who felt supported and protected are more likely to go above and beyond 
expectations to provide patient care. 
 He et al. (2017) completed a cross-sectional, multi-state survey offered to Oncology 
Nursing Society (ONS) members (N = 654) to examine whether the organization’s safety culture 
correlates to nurses’ use of PPE. The study involved nurses working in ambulatory care centers 
in three states in the United States. Nurses self-reported perceptions of low risk to HD exposure, 
limited PPE availability, and workload demands that may influence compliance with safety 
measures. He et al. suggested that nurse managers actively monitor and adjust nurse/patient 
ratios, ensure that supplies are readily available, and provide ongoing PPE training.  
The most recent study by Friese et al. (2019) concluded that despite decades of research, 
PPE use remains suboptimal and suggested that professional organizations, policymakers, 
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clinical experts, and health systems align to guide best practices. Friese et al. recommended that 
nurse educators standardize curriculum and reinforce personal accountability regarding safe 
handling and PPE use. Unfortunately, efforts to improve adherence through learning modules 
and self-report questionnaires failed to change nurses’ behaviors and attitudes about PPE use (N 
= 396). 
DeJoy et al. (2017) examined predictors of PPE use, safe-handling components, and 
adverse events associated with HD exposure in nurses (N = 1,814) and concluded that adherence 
to guidelines is inconsistent. Interestingly, PPE use was worse and less predictable among more 
experienced nurses. The study assessed the safety climate, nurses’ perceived safety culture with 
PPE, engineering controls, and adverse events with IV HDs. A comprehensive health and safety 
program emphasizing hazard controls was suggested to promote safe behavior and compliance 
among all HCWs (DeJoy et al., 2017). 
Research conducted in ambulatory oncology practices supports stricter, even mandatory, 
PPE utilization and endorses environmental and biological monitoring for the detection of 
harmful residues (Bohlandt et al., 2017). Recommendations for HD controls focus on better 
engineering controls, such as closed-system transfer devices (CSTDs) and biologic safety 
cabinets; administrative controls, such as policies and procedures and access to information; 
work practice controls, such as acuity-based scheduling and reducing workloads; and compliance 
enforcement. Most importantly, nurses are aware of the hazards associated with exposure, but 
continue to exhibit risky behavior (Bohlandt et al., 2017).                                                                                          
Rationale / Conceptual Framework 
The Orem model of nursing, or self-care deficit nursing theory, was developed by nursing 
theorist Dorothea Orem and covered a broad spectrum of general concepts for nursing 
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consideration and application (Alligood, 2014). The theory is comprised of three related parts: 
(a) the theory of self-care, (b) the theory of self-care deficit, and (c) the theory of nursing 
systems. Some of the theory’s relativity to this project include: a person’s knowledge of potential 
health problems is needed for promoting self-care behaviors, the prevention of hazards to human 
life and wellbeing, and the responsibility for their care, as well as others who require care. This 
model depicts how health professionals have as much of a responsibility to care for themselves 
as they would care for others (Vincent et al., 2016; Younas, 2017). 
Donabedian’s conceptual model, developed in 1966, provides a framework for 
developing, implementing, and evaluating this intervention (McDonald et al., 2007). Applying 
the components of the model includes the assessment of the structure, process, and outcomes 
relative to ambulatory infusion centers associated with the management of HDs. According to 
Donabedian, the physical setting would be the cancer center. The elements would include the 
mission, vision, and values of the organization; leadership skills; staff knowledge; adequate 
staffing and scheduling; well-designed workspace; and patient population. Other elements to 
support a safety culture include having the proper equipment to perform the tasks involved. 
The process includes interventions to safely deliver HDs, such as highly trained oncology 
infusion nurses. Developing standard work and tip sheets that specify the steps for each stage of 
handling would be considered process outcomes. Evidence-based guidelines and regulatory 
mandates affecting HCWs and patient safety are outlined in the USP <800> standards. Finally, 
an outcome is a final product combining both structure and process. A favorable outcome would 
have a sustainable structure and process that reduces the risk of HD contamination at all stages of 
HD handling and HCW adherence to PPE policy requirements. Poor outcomes allow for failures, 
such as inconsistent PPE use or other risky behaviors by HCWs contrary to EBP 
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recommendations. Other relevant outcomes include improved patient perception of safety 
captured in patient satisfaction surveys and reduced costs associated with employee monitoring 
for HD exposures. Nurses’ attitudes and perceptions about self-preservation will become the 
norm and align with policies and procedures meant to protect the population. 
Specific Aims 
The objectives were to develop an HD safe-handling PPE toolkit to learn if infusion 
nurses’ adherence to PPE use would improve to 90% or higher with HD handling and comply 
with the USP <800> standards and hospital policy by February 1, 2020. The specific aims were 
to determine if (a) based on direct observation, nurses comply with USP <800> requirements and 
hospital policy when administering and disposing of IV chemotherapy; (b) based on nurse self-
assessment, PPE standards and hospital policy were followed at least 90% of the time; and (c) if 
any differences are noted in nurses observed and self-assessed adherence to PPE standards and 
hospital policy. If differences were noted, additional peer-to-peer coaching would be considered 
until 90% compliance had been reached. 
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Section III. Methods 
Context 
PPE is critical for handling HDs at every step in the process. The AIC nurses require 
systematic training on PPE selection, donning and doffing, and disposal of contaminated 
materials to improve compliance with hospital policy. According to Friese et al. (2019), 
“Education and engagement of nursing personnel are not sufficient to improve PPE use.  
However, systematic approaches may result in improved practice” (p. 255). The intervention 
included the development of an HD safe-handling PPE resource toolkit to help guide best 
practice, according to Friese et al.’s recommendations. 
The key stakeholders included the AIC staff, the assistant unit manager (AUM), the 
cancer center executive director, the director of clinical oncology services, the cancer committee, 
and the environment of care workstream group. The USP <800> committee provided a systems-
thinking perspective, as the project results may apply to other affiliated AICs. The cancer 
committee approved this project as one of its QI initiatives for 2019. The project meets the 
Commission on Cancer Accreditation’s 2019 Program Standard 4.8 (quality improvements).  
Finally, USP <800> standards enforce organizational compliance with all applicable HD 
requirements. 
Intervention 
The DNP project was conducted in an AIC adjacent to a large tertiary medical center 
campus. The staff consists of 15 registered nurses, two patient care associates, one AUM, and a 
unit secretary. Only 10 nurses were eligible to participate because of their years of experience in 
oncology (> 2 years). The five excluded nurses included one nurse retiring, one nurse on 
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maternity leave, and three nurses with less than one year of infusion experience. The AIC is open 
seven days per week, and nurses generally work 10-hour shifts from 8:00 a.m. to 6:30 p.m.  
The interventions were implemented after approval from the hospital’s Internal Review 
Board (IRB) on October 6, 2019 (see Appendix B and Appendix C), but preliminary project 
planning began in June 2019. A Statement of Non-Research Determination was presented and 
approved by the University of San Francisco’s (USF) DNP committee. The project began on 
September 15, 2019, and ended on March 31, 2020. Upon completion, the revised HD policy 
became available and required the DNP student to review changes with all AIC staff.  The 
interventions consisted of: 
• Introduction of HD safe-handling PPE toolkit 
• PPE observation tool (Hennessy & Dynan, 2014) 
• Observations of chemotherapy safe-handling adherence tool 
• PowerPoint discussion 
• PPE skills session at annual skills day 
• Safe-handling adherence between observation and self-assessment survey 
• HD administration safe-handling peer-to-peer checklist 
• Use of performance dashboard 
Gap Analysis 
Better access to education is needed to ensure that employees are fully aware of the risks 
of adverse health consequences from HDs (Boiano et al., 2014). Gaps specific to the AIC 
included scheduling demands and workload pressures facing nurses in the unit. For example, 
nurses were scheduled 10 to 12 patients per 10-hour shift. After a literature review revealed that 
the number of patients assigned per nurse/per day significantly influenced total HD precautions, 
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scheduling templates were redesigned to accommodate six to eight patients per shift 
(Mendelsohn-Victor et al., 2017). Acuity levels for all therapies were reconfigured, and the 
adjusted levels went from 25 acuity points per day to 20 acuity points per day. Fewer patients per 
nurse, with balanced acuity levels, is the goal; yet. both can change dramatically throughout the 
workday, jeopardizing real-time safety. 
The lack of access to PPE supplies and environmental constraints contributed to the lack 
of willingness by nurses to change behavior on their own. Approximately 90% of the time, all 
required PPE was unavailable in the unit. This included shortages of chemo-protective gowns, 
booties, face shields, and eye protection. Structural changes were done to reduce barriers in some 
cases (see Appendix D. Gap Analysis). Not all exposure risks involve nursing practice; each step 
in the handling process should be managed appropriately. EBP, policies, and procedures; 
engineering controls; unit-based workplace designs; and the HCWs’ commitment to improving 
safety must guide processes and outcomes (Callahan et al., 2016). 
Gantt Chart 
The execution was divided into four phases, as outlined in the Gantt chart (see Appendix 
E). Phase one began on September 15, 2019, before formal IRB approval, as the organization’s 
USP <800> committee was working on the PPE requirements and invited the DNP student to 
join the group. Written organizational IRB approval was received on October 6, 2019; however, 
verbal approval was given on September 15 to begin the QI preparations. The cancer committee 
pre-approved the project in June 2019 at their quarterly meeting. Nurses were provided an online 
survey platform called SurveyMonkey to access a self-assessment of a safe-handling 
questionnaire in the second phase. A PPE observation tool was used to evaluate nurses’ actual 
compliance over two weeks following the survey. The third phase provided nurses with 
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information about USP <800> standards for PPE via PowerPoint presentation, PPE skills 
demonstration, and the HD safe-handling toolkit at a staff meeting in December 2019. Phase four 
began January 15, 2020, and included peer-to-peer feedback for identified problems during the 
observation phase. Data collection was being done as the USP <800> committee finalized the 
HD policies and procedures for the organization. The DNP student oriented the nurses to the new 
policy changes and toolkit location on the intranet.  
Work Breakdown Structure 
The purpose of the work breakdown structure (WBS) is to have a plan and infrastructure, 
supporting documentation and metrics tools, comprehensive education strategies, and a 
monitoring plan to maintain fiscal responsibility and increase chances of sustainability for the 
intervention (see Appendices F, G, H). Since the organization has been proactively preparing for 
USP <800> since 2016, this project served as an adjunct to other administration processes 
requiring PPE changes and ensured that the cancer center was included in the workgroups.  
There are five phases of development in the WBS: initiation, planning, execution, control, and 
close-out.  
During the initiation phase, the project manager attended various USP <800> workgroups 
to share information about the proposed DNP project and to elicit recommendations specific to 
requirements for IRB approval. All committees approved the project plan. A preliminary scope 
statement was completed, and the final project plan was shared with the cancer committee for 
final approval at their quarterly meeting. The execution phase included a kickoff meeting 
verifying USP <800> PPE requirements and introducing the toolkit purpose and design, PPE 
needs, and testing processes. Staff training and the go-live date were coordinated with the 
manager. The control phase of the WBS included project management, project status meetings, 
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risk management, and updating the project management plan. Finally, the close-out phase was 
one of the essential aspects of the project. An audit procurement and lessons learned session is 
instrumental because all of the completed steps were analyzed and reported to the committees. 
All files and records were collected and archived. Portions of the toolkit were placed on the 
intranet for all employee access during work hours under the heading “Resources” and 
“Hazardous Drug Administration.” 
SWOT Analysis 
The SWOT analysis (strengths, weaknesses, opportunities, and threats) is a useful tool for 
identifying the factors impacting the success of the project (see Appendix I). The major strength 
is that the organization was using a systems-thinking approach to implement the USP <800> 
standards before the February 1, 2020, deadline. Executive leadership and frontline managers 
worked together to address issues found in the gap analysis and made adjustments. Par levels for 
PPE were adjusted with central supply chains. Standards of practice were aligned across the 
health system to improve communication regarding PPE use. 
The most significant weakness was the nurses’ reluctance to wear PPE. Even after 
focused training and reminders, nurses remain complacent (Friese et al., 2019). Without 
addressing the negative attitudes about PPE use, improving safety will remain unsustainable. 
Opportunities to comply with USP <800> specific to PPE use are also receiving attention from 
the public, as exposure to HDs becomes a threat to patients in the home and in community 
settings. The increase in demand for more comprehensive patient education and internet searches 
calls for nurses to step up to the challenge. 
 The significant threats external to the organization may be associated with the high cost 
of equipment (PPE), HCW health monitoring, and recruitment and retention of qualified infusion 
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nurses. Also, there may be a loss of funding in the coming years for healthcare programs that 
strive to meet the demands of the 21st Century Cures Act. This legislation will increase Medicare 
infusion access to eligible patients and impose significant financial disincentives to home 
infusion pharmacy services. PPE and waste management strategies must remain part of the new 
legislation to prevent the dumping of chemical waste into communities and to ensure access to 
appropriate PPE for nurses. 
Responsibility / Communication Matrix 
The QI project complimented a USP <800> workstream that existed to address the 
readiness of ambulatory care units by providing expertise and guidance and by addressing the 
unique needs of AIC staff requiring PPE for chemotherapy administration (see Appendix J). The 
cancer committee required updates in order to satisfy a 2019 QI initiative for accreditation. A 
smaller workgroup oversaw the procurement of PPE and reported the potential financial impact 
on the organization. Training AIC nurses required thoughtful efforts to minimize anxiety and 
stress to staff and their patients. The DNP student used a systems thinking process to ensure 
communication between all parties and to ensure the fair use of time and resources. 
Cost / Benefit Analysis 
 The need to evaluate the costs associated with establishing HD training and adequate par 
levels for PPE was realized early on and related to the complexity of the organization and work 
stream processes necessary to accomplish system wide implementation. Specific to the AIC, the 
training of staff on HD administration and PPE use was estimated to be around $3,425. In 
addition, the DNP student’s contribution of 215 hours was factored in at around $17,200. The 
PPE supplies and other available resources was grossly underestimated at $7,350 per week. This 
estimate was difficult to ascertain because the supplies were bundled into facility costs within the 
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current budget system. However, individually purchased PPE items were extracted directly from 
a list provided by central supply services upon request. A discussion about where to store the 
toolkit, whether desktop or on the intranet, would determine the actual cost of providing up-to-
date HD resources and tools for all staff in high-risk areas. Structural changes and additional HD 
waste management containers were also required before project implementation to ensure that 
access to safe disposal of HD waste could be accomplished. 
 According to the Workers Compensation Insurance Rating Board (WCIRB, 2017), the 
2017 California indemnity claim averaged $37,054, which was the 5th highest-reported claims 
cost in the United States. The average claim is 40% higher than the median average nationwide. 
With this cost risk in mind, and applying it to 10 HD exposed nurses, the cost for one year of 
treatment and surveillance would be more than $370,540 per year. The average California claim 
is reported as paid over three years, at a cost of $1.1 million for 10 potentially exposed nurses. 
The organization is self-insured and utilizes internal services to provide care to employees who 
have been affected in order to reduce the burdens associated with the adverse effects of HD 
exposure on health and wellbeing. The benefits of implementing an HD safe-handling program 
far outweigh the costs associated with care required for adverse consequences. 
The AIC is a high utilizer of PPE, and essential cost factors were not realistic in the 2019 
budget. With 2,800 patient visits per month expected in 2020, the costs of providing PPE to 
nurses for 80% of patients are daunting. The projected annual costs for PPE procurement will be 
increased by 20% in the upcoming 2020 budget. The increased costs do not include unforeseen 
events associated with flu season or potential pandemic situations. Non-monetary benefits 
include ethical, moral, and harm reduction efforts to protect staff and patients and cannot be 
quantified into a dollar amount. The budget estimates document depicts financial projections for 
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implementing the project (see Appendix K, L, and M). The toolkit will be placed on the intranet 
and will not require printing, as previously planned.   
Study of the Intervention 
The PPE observation tool was used to collect pre-intervention data to evaluate the current 
state of adherence to PPE use with HD administration. To assess observations of handling, 
administering, and disposing of chemotherapy, a 15-item yes or no nurse skill checklist was 
used. To retrieve self-assessments of nurses’ adherence to PPE use and to follow hospital 
policies, a 15-item questionnaire, using a 5-point Likert scale response set, ranging from 0 
(never) to 4 (always) plus a not-applicable option, was designed on SurveyMonkey. Also 
collected and analyzed were the nurses’ professional characteristics through the self-assessment 
survey questions using checkbox and fill-in-the-blank responses. 
Analysis 
Data analysis involved describing the nurse skills checklist frequencies and self-
assessment of RN characteristics using medians and quartiles of counts and percentages for all 
categorical variables. Mean scores for the 15-item self-assessment questionnaire on PPE use 
were calculated by averaging responses across administration, disconnection, and disposal of 
chemotherapy. After matching factors for the nurse skills checklist and self-assessment 
questionnaire, data were compared to learn if differences exist in adherence to PPE and hospital 
policies for safe handling.   
Ethical Considerations 
One of the core Jesuit values is forming and educating agents of change, which means 
teaching behaviors that reflect critical thought and responsible action on moral and ethical issues.  
Infusion nurses must change attitudes and behaviors about PPE use because of the high-risk 
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nature of harm with HD contamination. It is morally and ethically irresponsible to subject others 
to harmful toxins because of one’s actions. This evidence-based improvement project, suggestive 
of individualizing the care and attention to HCW safety, was also intended to promote patient 
safety and maintain the highest standards of care, in accordance with the Jesuit values for all 
people and the environment.  
 The American Nurses Association’s (ANA, 2015) ethical standard that relates to this 
EBP project is Provision 3, “The nurse promotes, advocates for, and protects the rights, health, 
and safety of the patient” (p. 9). Provision 3.4 of the ANA Code of Ethics states that nurses have 
a professional responsibility to promote a culture of safety. This provision extends beyond 
reporting events and errors that occur to patients and includes “adherence to policies that 
promote patient health and safety” (ANA, 2015, p. 12). This project empowers nurses to 
establish habits that protect patients from involuntary HD exposure. Efforts were made to 
minimize the psychological stress nurses and patients may have felt while participating or 
observing the intervention by informing them of the new safety regulations in place to increase 
safety in the AIC.   
On September 1, 2019, the USF DNP department determined that this project met the 
guidelines for an evidence-based change in practice project, as outlined in the DNP project 
checklist (statement of determination) and was approved as non-research. There are no 
identifiable issues or conflicts of interest noted for this project. On October 6, 2019, the IRB of 
the healthcare organization also approved the request to move forward with the project (see 
Appendix B). As a non-research project, the IRB approved its implementation. The QI initiative 
was also an improvement endeavor through the University of San Francisco’s Professionals (see 
Appendix N). 
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Section IV. Results 
The purpose of this section is to describe the results obtained from the tools developed to 
improve AIC nurses’ compliance and adherence to PPE use during chemotherapy handling. The 
initial survey assessed the personal demographics of respondents related to the practice of 
nursing, as well as individual practices and behaviors associated with the administration of IV 
antineoplastic drug administration in the AIC setting.  
Surveys 
Responses to Survey 
A total of 10 surveys were completed from an eligible group of 10 registered nurses. The 
initial survey request was not well-received, so another attempt was made, yielding all 10 
possible survey responses (100% return). All participants reported two or more years of 
oncology experience, possession of a chemotherapy and biotherapy card, and that their position 
required the handling, administration, and disposal of IV chemotherapy and HD waste. No 
missing data were noted, as the survey was set up via SurveyMonkey so that respondents could 
not skip any questions. Most participants were middle-aged (range = 25 years to 68 years, SD = 
14), with an average age of 44 years. Seven of the 10 nurses had earned their Oncology Certified 
Nursing (OCN) credential (70%) and reported they were members of the Oncology Nursing 
Society [ONS] (70%). Most staff worked 10 hours per day, and the average caseload managed 
per day for chemotherapy and non-chemotherapy treatment was 10 (range = 5 to 12, SD = 1.84).  
Descriptive Statistics 
The tables in Appendix O display the descriptive statistics. Sample demographics are 
displayed in Table 1. Table 2 shows the results of the Nurses’ Self-Assessment of Adherence to 
the Chemotherapy Safe-Handling Survey. Table 3 displays Observations of Chemotherapy Safe-
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Handling Adherences in Number of Events. Table 4 displays Differences between Nurses’ Self-
Assessment of Adherence from Survey and Direct Observation of Adherence. 
Handling and Administration 
Fifty percent of nurses reported using absorbent pads on work surfaces for chemotherapy 
agents, but only 32% were observed doing so (n = 50 events). All scores in the handling and 
administration category were below the 90% threshold of adherence to hospital policy on HD 
safe handling. However, nurses scored themselves lower in all categories than what was 
observed. It is possible that after the nurses took the self-assessment survey, they considered 
some of the actions worthy of immediate practice adoption and change. 
Disconnecting and Discarding 
None of the nurses stated that they wrapped a gauze pad around the connection (CSTD) 
when disconnecting chemotherapy tubing, leaving the chemotherapy bag attached. An 8% 
improvement in practice was observed after the survey was completed. There were two other 
discrepancies noted between the self-assessment and observation results that were concerning. 
Nurses reported that 90% of the time, gloves were disposed of in a chemotherapy-approved 
container. Seventy percent of nurses reported washing hands after disconnecting chemotherapy. 
Only one observation met the 90% threshold, which indicated that chemotherapy was discarded 
with the attached tubing into a chemotherapy-approved waste container. Nurses also self-
reported a 10% compliance with wearing two pairs of chemotherapy-approved gloves and 
chemotherapy-approved gown when handling chemotherapy.   
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Section V. Discussion 
Summary 
The purpose of this section is to provide a summary of results obtained from the QI 
project done in the hospital’s outpatient AIC located in the cancer center. This section explains 
the role of the DNP-prepared clinician as it relates to the application of the project. Furthermore, 
the project aims, key findings, lessons learned, and how the project contributed to improving the 
compliance and adherence to USP <800> and hospital HD policies and procedures related to 
PPE use are presented. 
Although the health risks of HD exposure are well documented, AIC nurses reported 
suboptimal overall adherence to safe-handling precautions when administering chemotherapy.  
These findings are consistent with the literature, as they reinforce that recommended practices, 
despite the availability of published safety warnings by professional organizations such as the 
ONS, NIOSH, and others, are inconsistent (Boiano et al., 2014; Polovich & Olsen, 2017).  
According to the Safe-Handling Adherence between Observation and Self-Assessment results, 
the use of double-gloving and donning/doffing PPE were rarely used by AIC nurses before the 
intervention. The PPE toolkit was introduced and outlined specific PPE-wear in multiple 
scenarios, including oral chemotherapy administration (see Appendix P).   
The project aims were achieved, in that nurses’ understanding of the purpose of USP 
<800> standards improved, compliance and adherence to PPE use improved, and hospital HD 
policies were followed. PPE use also may have improved as supplies became more accessible in 
the patient treatment areas and were restocked routinely by central supply services. One critical 
lesson learned was that unit culture matters. The nurses who were late adopters in wearing PPE 
criticized participating nurses as being wasteful of valuable resources. Nurses did not hold each 
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other accountable for nonadherence. However, the USP <800> standards seemed to be the 
driving force for improving compliance and adherence for both the organization and the AIC 
staff. The AUM also had leverage to discipline staff who failed to follow the new policy 
mandates now published throughout the organization.  
Unfortunately, competing priorities due to the COVID-19 pandemic in March 2020 
affected the availability of PPE supplies around the world. During the shortage, the ONS (2020), 
at the request of its members, developed a position statement on PPE use and provided 
alternative solutions for infusion nurses to conserve resources. While this was not ideal, nurses 
felt healthcare providers on the frontlines of treating COVID-19 infected patients should receive 
priority. Staff returned to old habits and ignored policy mandates, mostly because of unit culture 
acceptance, a lack of PPE availability, and because there was little chance to comply with all the 
new requirements fully. A post evaluation survey will be completed in the next six months. 
The opportunity to truly understand how and why PPE is necessary may fall on the next 
generation of nurses. Annual PPE learning modules, unit culture changes, online resource tools, 
and trained staff champions are vital components of a culture of safety in the AIC. The 
implications for advanced practice nursing include educating all nurses on environmental risks 
and increasing awareness of the consequences of non-compliance associated with social justice.  
Finally, when an organization employs oncology infusion nurses, PPE use must be demonstrated, 
enforced, and viewed as a critical function of everyday responsibilities. 
Interpretation 
Clark et al. (2014) discussed the role that organizations play in influencing employee 
behavior regarding safety climate and citizenship behavior. Providing consistent messaging 
about HD exposure on health, reinforcing safe-handling behaviors, and ensuring the availability 
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of resources improved the basic understanding of handling toxic agents with care. He et al. 
(2017) recommended removing barriers, such as modifying the nurses’ workload and 
environment of care. During the weeks after the PPE intervention and toolkit introduction, 
changes were made to the scheduling templates, thereby reducing patient to nurse staffing ratios. 
The number of patients assigned to one nurse decreased from 10 to 12 patients per shift to six to 
eight patients per shift. Nurses felt that this change allowed for more quality time with patients 
and provided more opportunities to don PPE during each encounter, if needed. In addition, an 
acuity rating for each therapy was adjusted that identified how patients would be divided 
amongst the nurses. The average acuity ranges for therapies assigned to one RN dropped from 20 
to 25 points per 10-hour shift to 15 to 20 points per 10-hour shift. One hour was left available in 
each morning schedule to accommodate add-ons and unit-of-service changes based on patient 
status. 
Despite the availability of PPE and new standards, best practice does not always produce 
the intended results. Optimal levels of compliance and adherence were only achieved for a brief 
period due to an enhanced focus on the process measures. It truly highlights the importance of 
training and education, role modeling, and providing data to support a task that is unpleasant and 
whose results have not been quantified at this time. Also, competing priorities, such as the PPE 
diversion to critical areas of need during the pandemic, may have delegitimized the need for 
safe-handling measures in the AIC setting. Changing the rules for PPE use during COVID-19 
may have also reinforced preconceived ideas held by AIC nurses that one problem is more 
important than the other. The difference, in this case, is that the virus exposure cases were 
measured continuously and reported publicly, while HD exposure incidents are rarely discussed.   
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The Orem model of nursing or self-care deficit nursing theory was useful in evaluating 
the progress and outcomes of the project and is widely adopted in the current organization’s EBP 
culture. Conceptually, the context was explored by completing an assessment of the organization 
and the AIC’s systems of care and discovering the variances between the needs and expectations 
of the macrosystem and microsystem. The culture of safety and contributing factors were 
evaluated to investigate any mitigating concerns and to understand the systems-thinking process 
fully. Current scientific literature was reviewed to determine its applicability to the unit, and key 
stakeholders were identified to act as project facilitators and project advocates. Orem’s model of 
nursing provided an excellent conceptual framework for reviewing the evidence, context, and 
facilitative leadership gaps that impeded the ability for nurses to provide safe handling of HDs, 
as well as guided the translation of evidence that contributed to the toolkit’s final development. 
Donabedian’s model was used to examine the AIC environment and to assess the quality 
of care issues (McDonald et al., 2007). In this intervention, exploring the components of this 
framework (structure, process, and outcomes) led to a better systems-thinking approach and to 
the implications and influence the project had for other AICs. Again, in Donabedian’s 
framework, the AIC concept of structure is associated with the organization’s characteristics of 
the physical infusion center space, while the process involves the actual services provided to 
oncology infusion patients. The outcome is the result of those measures. Relative to participants, 
most were 40 to 59 years of age, certified in chemotherapy administration, and possessed a 
bachelor’s degree in nursing. The hospital only hires nurses with a bachelor’s degree or higher; 
however, nurses who were employed greater than 10 years who earned a diploma or associate 
degree in nursing continue working at the facility. By the end of the QI project, new scheduling 
templates decreased the patient volume and balanced the patient acuity from 10 to 12 patients per 
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day to six to eight patients per day. The resource toolkit was added in the resource library under 
the heading “Hazardous Drugs” on the intranet site, which is accessible to all nurses throughout 
the healthcare system. 
Nursing educators should include environmental and occupational health courses in the 
core curriculum to teach about the risk of HD exposure. The role of the DNP has been significant 
in educating nurses in the AIC through the use of an HD toolkit on environmental hazards 
associated with HD exposures. The DNP, as a clinician and clinical nurse leader, has a distinct 
role in presenting EBP strategies and how they might influence care in the AIC setting. Through 
leadership, the DNP has established solid systems-thinking relationships with critical 
stakeholders and facilitators that enabled the positive progression of shared responsibility with 
HD handling. As an advocate, the DNP seeks to improve the long-ignored quality and safety of 
AIC nurses. Through scholarship, the DNP reviews the literature for applicability to the care 
setting, identifies gaps between oncology research and practice, and explores potential solutions 
that promote the safest care possible for staff, patients, and their families. The DNP, as an 
innovator, must evaluate the macrosystem and implement practice improvement that 
complements the needs, mission, and values of the organization. As an educator, the DNP 
teaches others about the significance of a problem and the reason change is required. The 
educator role also offers evidence-based recommendations for the clinic based on results from 
current or historical landmark studies concerning HD safety. 
Limitations 
There were several limitations to this QI project. The survey only pertained to one AIC in 
one organization with a small sample size (N = 10) of experienced oncology infusion nurses. A 
multi-center approach would increase the value of the findings related to PPE adherence in AICs. 
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There is also a potential for lack of inter-rater reliability, given that the nurses were evaluated 
multiple times on different days by different observers during the collection of data with the PPE 
observation tool. The nurses who completed the self-assessments may have been different from 
the ones who were being observed each day. Staff were reluctant to participate because they did 
not want to perform the full PPE requirements. 
 The enforcement of PPE use was not part of the unit’s culture of safety, and most of the 
nurses were long-time employees who objected to wearing PPE. It took three separate attempts 
to get the initial survey completed because of the lack of interest in changing behavior. All 
nurses had a current Chemotherapy and Biotherapy Administration card and were aware of the 
best practice guidelines for wearing PPE with HD administration. The change in behavior relied 
upon the USP <800> standards and HD policies as the driving force for improving compliance 
and adherence. The resource toolkit provided instructions on how to achieve and measure those 
desired outcomes.  
Before the intervention, several concerns were identified: (a) nursing staff did not wear 
PPE other than a single pair of chemotherapy-tested gloves; (b) most nurses had worked together 
since the center opened more than six years ago and did not want to wear PPE; (c) nurses 
indicated that PPE was only a recommendation, so it was a nurse’s choice; and (d) lack of 
adequate PPE supplies. The DNP student utilized a systems-thinking leadership approach and 
met with housekeeping, central supply, cancer committee leadership, and others to procure the 
items required for the safe delivery of HDs. A PPE cart was set up, and plans were made to 
restock items each morning. New HD waste bins with larger openings were ordered and placed 
strategically in the unit for ease of chemotherapy waste disposal. Faucets were replaced to 
accommodate three eye wash stations. Additional sharps containers were provided in each 
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treatment pod, and staff participated in choosing the location for each new item. The DNP 
student also worked with the information technology department to discuss the possibility of 
whether an HD toolkit could be included in the current workflow area labeled “Hazardous 
Drugs” on the systems’ intranet under “Resources.” 
Conclusions 
This project has multiple implications for future QI projects. Information associated with 
a personal motivation for compliance and adherence with safe-handling standards needs to be 
studied. This is especially significant since the HD toolkit is only as good as the motivation 
required by nurses to search for information on proper PPE choices. The project suggests that 
despite the high potential for HD residue exposure, staff perceptions about personal risks for 
contamination remain low, and even information about HD precautions on demand did not 
change how nurses comply or adhere to evidence-based knowledge. Clinically, the best options 
are to determine which barriers exist that prevent optimal safe handling from occurring and 
eliminate or minimize them in every situation. Also, by reducing the volume of patients treated 
by a single nurse in a shift, it would be interesting to know if this factor alone could increase PPE 
use and minimize exposure risks. The organization’s motivating efforts to educate and inform 
staff of potential HD exposure lies in the enforcement of the USP <800> standards and other 
regulations it is now required to uphold. Many nurses felt that the organization’s position on the 
safe handling of HDs was evolving and that current guidelines met their safety expectations. 
More efforts are needed to collect and disseminate national exposure risk data to share the 
magnitude of this problem.  
As the population of cancer patients and survivors grows, AICs will be challenged to 
improve the quality and safety of their work environments and reduce the occupational risks of 
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HD exposure. More focus on outpatient settings regarding safety processes and more efficient 
methods to share critical information is needed. The focus on modifying the work environment 
to improve safety by establishing HD toolkits as resources, the innovative development of 
environmentally-safe PPE, and mandatory HD policies must be established, in combination with 
a systems-thinking approach, to solve these multi-layered gaps in quality and safety. This clinical 
intervention demonstrates that data showing the risks associated with HD exposure on HCWs are 
sorely needed to make a case and to change risky behavior with PPE handling during 
chemotherapy administration. 
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Section VI. Other Information 
Funding 
Long Beach Memorial Medical Center and the Todd Cancer Pavilion Cancer Committee 
executive director and other staff members funded this QI project. There were no other funding 
needs required for the project.
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Section VIII: Appendices 




Citation  Statistical Tools Data Collected Quality of Evidence  Highlights from Article 
Bohlandt et al. 
(2017) 
Wipe samples/surface 
monitoring, urine collection, 
questionnaire on household.  
Analyses carried out under 
strict internal and external 
quality assurances; 
SPSS Version 21; 
Spearman rank correlation 
test/Mann-Whitney-U test for 
independent variables. 
 
Setting: Patient homes s/p 
chemo admin 
Sample: 
1) 265 wipe samples/13 
homes at two times after 
chemo from common 
household surfaces.  
2) 62 urine samples from 
patients and family members 
on three days.  
3) Drugs analyzed: 
cyclophosphamide (CP), 5-
fluorouracil (5-FU), and 
platinum (PT). 
Time Frame: Up to 4 days 
Results: Substantial 
contamination on every 
surface type (PT: 0.02-42.5 
pg/cm2; 5-FU: ND 






Spot samples, both wipe and 
urine samples, only reflect the 
current situation and that 
probably different results may 
have been found when 
performing continuous urine 
collection.  
Aim: To evaluate the surface 
contamination and the 
potential uptake of 
antineoplastic drug residues 
by family members at home 
of chemotherapy patients. 
 
Exposure was evident in 
patient homes on various 
surfaces. Adequate hygienic 
and protective measures are 
necessary to minimize the 
exposure risk for cohabitants. 
 
Elevated levels in patient’s 
urine more than 48 hours, no 
drug residues in family 
members’ urine. 
Boiano et al. 
(2014)  
 
NIOSH Survey of Healthcare 
Workers (an anonymous, 
multi-module, web-based 
survey), SAS 9.3 to analyze 
data. 
Setting: NIOSH web-based 
survey 
Sample: 98% of 2,069 
respondents were nurses 
Time Frame: Jan 28 to Mar 
29, 2011 
Results: The survey results 





Survey was targeted to 
members of professional 
practice organizations and are 
not generalizable to all 
Authoritative guidelines are 
not being universally 
followed. 
 
Activities that increased 
exposure risk per 
respondents, included: failure 
to wear nonabsorbent gown 
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the lack/infrequency of 
training, awareness of 
employer procedures, and 
awareness of national safe-
handling guidelines. 
Multiple breaches in safe 
work practices (CSTDs, luer-
lick fittings, needleless 
system). 
healthcare workers or to all 
members of each of the 
participating professional 
organizations. 
The survey was only 
available to members with 
email addresses and internet 
access. 
 
with closed front and tight 
cuffs (42%), IV tubing 
primed with antineoplastic 
drug (6%) or by pharmacy 
(12%), potentially 
contaminated clothing taken 
home (12%), gloves (12%), 
lack of hazard awareness 
training (4%). 
 
Most common reason for not 
wearing gloves or gowns was 
“skin exposure was minimal,” 
but respondents reported skin 
contact during handling and 
administration. 





correlational design study. 
Survey Hazardous Drug 
Handling Questionnaire. 
Data were analyzed using 
descriptive statistics and 
multiple regression analysis. 
(main research variables: 
exposure knowledge, self-
efficacy, perceived risk, 
interpersonal influences, and 
workplace safety climate). 
Survey Monkey software 
database, SPSS V21.0, 
Spearman’s correlation 
coefficients, 
Wilcoxon rank sum tests.  
Setting: The National 
Institutes of Health Clinical 
Center in Bethesda, Maryland 
Sample: 196 eligible/115 RNs 
working on high-volume HD 
administration units. 
Time Frame:   
Results: Total mean HD 
precaution use proved highest 
during HD administration and 
lowest for handling excreta at 
48 hours. Average patients 
per day significantly 
influenced total HD 
precaution: more precaution 






Self-report survey conducted 
in one specialized research 
hospital and cannot be 
generalized without 
replication to other settings. 
Nurses were required to 
attend formal training to 
administer chemo and 
biotherapy and gain oncology 
nursing certification 
Purpose: To identify factors 
associated with oncology 
nurses’ use of HD safe-
handling precautions in 
inpatient clinical research 
units. 
 
Data were analyzed using 
descriptive statistics and 
multiple regression analysis. 
(main research variables: 
exposure knowledge, self-
efficacy, perceived risk, 
interpersonal influences, and 
workplace safety climate). 
Conclusions: Despite high 
exposure knowledge, barriers 
to PPE use and conflict of 
interest may contribute to 
reduced adoption of personal 
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protective practices among 
oncology nurses. 
Hospitals and unit-specific 
factors captured by the 
predictor variables could 
contribute to institutional HD 
policy. 




study investigation to 
understand the relationship 
between safety climate and 
employees’ organizational 
citizenship behavior. 
Setting:  2 hospitals in the 
Midwestern United States. 
Sample: Focal nurses and 
their peers using paper 
surveys. 700 nursing 
professionals 
Timeframe:   
Results: The correlation 
between perceptions of safety 
and organizational citizenship 
behavior among nurse was 
good when role definitions 





Because nurses were able to 
choose their peers, there may 
have been positive bias due to 
interpersonal familiarity. 
Safety climate appears to be 
an important predictor linked 
to employee performance. 
Management must play an 
important role to ensure 
employee safety. By working 
together, the quality of patient 
care and safety increase and 
outcomes improved. 




study to compare objective 
and subjective nurse 
behavior, micro-ethnography 
and questionnaires. 
Setting: Cleveland Clinic 
Sample: 22 cases of chemo 
handling observed, 12 of 33 
nurses completed 
questionnaires. 
Time Frame: Jan 2012 to Mar 
2013 
Results: Data analysis 
involved describing the nurse 
skill checklist frequencies and 
self-assessment of RN 
characteristics using medians 
and quartiles of counts and 






Study conducted in a single 
center, and the sample size 
was small. 
Sample size for nurse 
observations was small. 
Lack of uniformity in 
assessment item working 
could have led to differences 
in reported frequencies in 
adherence to PPE 
recommendations. One nurse 
The aims of the pilot study 
were to examine actual and 
subjective ambulatory 
oncology nurse adherence to 
chemotherapy safe handling 
with NIOSH PPE and 
hospital policy exposure 
controls. 
 
Consistent adherence to 
practice expectations may 
require more than an annual 
competency assessment. 
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 may have been observed 
more than once on different 
days. Nurses observed had 
two or more years nursing 
experience in oncology 
nursing and may not have 
been well matched in the 
group comparisons. 
Analyses were based on 
group findings; no 
correlations were noted 
between observed behaviors 
and self-assessment by 
individual nurses. 
Chemotherapy exposure is a 
team concern in that one 
healthcare clinician can 
follow all policies, yet still be 
exposed to chemo if others 
fail to do so. 
Connor et al. 
(2014) 
 





• DTIC, Embase 





• PubMed, Risk 
abstracts 
• Toxicology Abstracts 







Setting: Literature review 
Sample: 18 peer-reviewed, 
English language publications 
of occupational exposure and 
reproductive outcomes 
studies. 
Time Frame: Literature 
review completed 1980 to 
February 2014 
Results: While effect sizes 
varied with study size and 
population, occupational 
exposure to antineoplastic 
drugs appear to raise the risk 
of both congenital 
malformations and 
miscarriage. Studies of 
infertility and time-to-
pregnancy also suggested risk 
for sub-fertility. 
Measurement of surface 





Small sample sizes 
5/8 studies had 10 or fewer 
exposed cases. All studies 
had fewer than 20 exposed 
cases. Limited ability to 
adjust for confounding; the 
need to group anomalies that 
had different etiologies and 
wide confidence intervals, 
which reflect poor statistical 
power.  
Antineoplastic drugs are 
highly toxic in patients 
receiving treatment and 
adverse reproductive effects 
have been well documented 
in these patients. HCW with 
chronic, low-level 
occupational exposure to 
these drugs also appear to 
have an increased risk of 
adverse reproductive 
outcomes. Additional 
precautions to prevent 
exposure should be 
considered (NIOSH). 
Some studies have shown an 
association between surface 
contamination and worker 
exposure. 
For pregnant women, the 
window of risk begins one 
month before conception and 






indicator of the level of 
environmental contamination 
in areas where Ads are 
prepared, administered to 
patients, or otherwise handled 
(such as receiving areas, 
transit routes throughout the 
facility, and waste storage 
areas). 
The odds ratio of adjusted 
models ranged from 1.36 
(95% CI, 0.59-3.14) to 5.1 
(95% CI, 1.1 -23.6) 
lasts through pregnancy (most 
vulnerable in first trimester). 
Breast milk is affected by HD 
exposure. 
A man’s sperm is vulnerable 
to HDs from as early as 2 
months before conception. 
Connor et al. 
(2016)  
 
Not stated Setting: Article review by 
experts at NIOSH 
Sample: not stated 
Time Frame: not stated 
Results: 
A comprehensive safe-
handling program for ADs 
may utilize wipe sampling as 
a screening tool to evaluate 
the environmental 
contamination and strive to 
reduce contamination levels, 
as much as possible, using the 
industrial hygiene hierarchy 
of controls. 
Level:  III 
Quality: A 
 
Wipe sample area 
recommendations: 
Nurses’ station storage area 
for IV bags 
Countertops 
Furniture in patient rooms 
Infusion pump 
Door handles, door knobs, 
other high-touch areas 
Computer keyboard/mouse 
Floor in patient room 
Floor in restroom 
The purpose of the article was 
to review published studies of 
wipe sampling for 
antineoplastic and other HDs, 
to summarize the methods in 
use by various organizations 
and researchers, and to 
provide some basic guidance 
for conducting surface wipe 









• Cochrane Library 
• EMBASE 
English language 
Setting: Systematic literature 
review 
Sample: 29 publications met 
final review criteria 
Time Frame: 1979 to 2014 
Results: 5 major strategies 
identified (engineering 
controls, PPE, medical and 
Level: III 
Quality: A 
The systematic review was 
conducted to identify 
evidence-based strategies for 
protecting all HCWs, from 
those involved in handling 
packaged HDs to those who 
dispose of body fluids of 
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environmental monitoring, 
hazard identification, need for 
comprehensive HD control 
program that includes 
education and training for 
HCWs). 
Transparency in every step in 
the chain of custody is 
needed. Clear signs or labels, 
including electronic 
identifiers, and clear 
instructions that prompt what 
to do next are needed. 
individuals taking these 
medications. 
One problem with wipe 
testing is that there is no 
minimum acceptable 
exposure level for 
chemotherapy or other HDs.  
Testing workers’ urine/blood 
samples may be difficult to 
operationalize across large 
healthcare systems. Financial 
and ethical implications must 
be considered, specifically 
with how to counsel staff 
members with positive results 
of urine or blood samples. 
 
Barriers such as 
understaffing, the physical 
layout of a unit, and time 
constraints can negatively 
impact adherence. 
DeJoy et al. 
(2017)   
Data came from the 2011 
NIOSH Health and Safety 
Practices Survey of 




Statistical analyses were 
performed using SAS 9.4 
software in three stages: (1) 
descriptive analyses, (2) 
factor analysis of safety 
perception, and (3) 
psychometric analyses. 
Setting: Online survey 
Sample: Nurses (N=1,814) 
who had administered IV 
HDs in the 7 calendar days 
prior to the survey and whose 
employer was either a 
hospital or ambulatory 
healthcare center. 
Time frame: Survey was 
available for 8 weeks.  
Results: The study showed 
lower likelihoods of exposure 
when staffing and resources 





• Cross-sectional study limits 
the ability to make causal 
interpretations. 
• Survey respondents were 
solicited from membership 
rolls of professional 
organizations and may not 
represent all nurses who 
administer HDs. 
Purpose/Objectives: To 
examine predictors of the use 
of PPE and engineering 
controls and adverse events 
involving IV HDs in a 
relatively large and diverse 
sample of nurses.  
The study examined the 
effects of pertinent 
organization safety practices 
and perceived safety climate 
on the use of PPE, 
engineering controls, and 
adverse events (spill/leak or 
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orders and doses were 
consistently verified by two 
nurses. 
• The sample was limited to 
nurses working in the U.S. 
• Data collected were 
analyzed at the individual 
level. 






skin contact) involving liquid 
antineoplastic drugs. 
14% of nurses reported an 
adverse event. 
 
Results point to the value of 
implementing a 
comprehensive health and 
safety program that uses 
available hazard controls and 
effectively communicates and 
demonstrates the importance 
of safe-handling practices. 
Such actions also contribute 
to creating a positive safety 
climate. 
   
Having an adequate 





PPE use was lower among 
nurses working in ambulatory 
infusion centers and be 
caused by less formalized 
safety programs and perhaps 
less direct supervision of 
those administering HDs. 
Both of these factors could 
lead to diminished adherence. 
Friese et al. 
(2019)    
 
 
Methods & variables:  
1. Revised Drug Handling 
Questionnaire (Martin & 
Setting: 12 ambulatory 
oncology settings in the 






evaluate whether a web-based 
intervention improved PPE 
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 Larson, 2003; Polovich & 
Clark, 2012) 
2. Practice Environment Scale 
(Friese, 2012). 
3. Safety Organizing Scale 
(Vogus & Sutcliffe, 2006) 
4. The authors measured 
knowledge of HD handling 
using a team-generated, pilot-
tested, 10-item questionnaire. 
5. Occupational Dermal 
Survey to measure perceived 
risk (Geer, Curbow, Anna, 
Lees, & Buckley, 2006). 
 
In a cluster randomized 
controlled trial, 136 nurses in 
control settings received a 
one-hour educational module 
on PPE use with quarterly 
reminders, and 121 nurses in 
treatment settings received 
the control intervention plus 
tailored messages to address 
perceived barriers and 
quarterly data gathered in HD 
spills across all study settings. 
The primary outcome was 
nurse-reported PPE use. 
 
The primary outcome was 
PPE use, as measured by the 
previously published Revised 
Drug Handling Questionnaire 
(Martin & Larson, 2003; 
Polovich & Clark, 2012). 
eligible, but 3 declined 
participating in study 
12 sites were randomized 
6 sites control arm 
6 sites allocated to 
intervention. 
 
Sample: 396 nurses, 257 of 
who completed baseline and 
primary endpoint surveys. 
 
Time frame: March 2015 to 
March 2017 
Results: Control and 
intervention sites had 
suboptimal PPE use before 
and after the intervention. No 
significant differences were 
observed in PPE-use 
knowledge or perceived 
barriers. Participants reported 
high satisfaction with the 
study experience. 
 
First, the study took place in a 
convenience sample of 
academic health centers with 
high-volume cancer 
programs. (Results may not 
generalize to smaller or 
community-based oncology 
settings). 
Second, the calculated 
reliability of the outcome 
measure in the current sample 
was relatively low (0.46 for 
the 3-item measure and 0.5 
for the 5-item measure 
considered in the sensitivity 
analysis). 
use among oncology nurses 
who handle hazardous drugs. 
 
Findings: It is clear that 
education and engagement of 
nursing personnel is not 
sufficient to improve PPE use 
– systematic approaches may 
result in improved practice. 
  
Conclusion: Despite four 
decades of research, current 
use of PPE remains 
suboptimal in ambulatory 
oncology settings. A theory-
informed, web-based 
educational intervention to 
RNs failed to improve PPE 
use in the ambulatory 
oncology setting. 
A multi-faceted strategy 
(equipment changes, 
standardized policies, 
educational efforts, and 
leadership support) across 
multiple levels (units, 
hospitals, and health systems, 
and professional 
organizations) may be 
required to improve 
adherence to HD-handling 
guidance. 
 
Implications for Nursing:  
HD exposure confers notable 
health risks to healthcare 
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workers. To improve HD 
handling, occupational 
healthcare workers, health 
systems, and professional 
organizations should consider 
coordinated efforts to 
implement policy and 
practice changes. 
 
Other Data of Interest: 
Future research efforts would 
benefit from development and 
testing of novel measures of 
PPE use and evaluation of 
optimal measurement times 
after delivering educational 
interventions and delivering 
study reminders. 
 
He et al. (2017)    
 
1.Cross-sectional, multi-state 
mailed survey to ONS 
members (N=654) 
Tool: Revised Hazardous 
Drug Handling Questionnaire 
(Martin & Larson, 2003; 
Polovich & Clark, 2012) 
2. Bivariate and multivariable 
regression analyses 
3. Covariates: nursing 
workloads, nurses’ practice 
environments, and barriers to 
PPE use 
4. Dillman’s total design 
method to maximize response 
rates (personalized cover 
letters, $40 cash incentives, 
Setting: Ambulatory 
oncology practices in CA, 
GA, and MI 
Sample: 252 ONS members 
who administer hazardous 
drugs 
Time frame: February to 
September 2014 
Results:  
437 nurses completed surveys 
(67% response). Final 
analytical sample (n=252), 
97% women, 79% 43 years or 
older, 75% with at least 6 
years of nursing experience, 
and 96% worked in outpatient 





The internal reliability of the 
dependent variable – the PPE-
use scale – was lower in the 
current sample (0.61) than 
previously reported (Geer et 
al., 2006).   
The distribution of various 
PPE (included on the PPE-
use scale) had a bimodal 
pattern; many respondents 
reported either using PPE 
very frequently or never. 
Purpose/Objectives: To 
examine patterns and 
organizational correlates of 
PPE use and hazardous drug 
spills. 
 
Findings: 26% reported 
recent drug spill, 90% wore 
only 1 pair of chemotherapy-
tested gloves. PPE use was 
associated with increased 
nurse participation in practice 
affairs, non-private 
ownership, increased nursing 
workloads, and fewer barriers 
to PPE use. Spills were 
associated with significantly 
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three monthly reminders to 
non-responders) 
5. Safety Organizing Scale to 
measure collective behaviors 
performed by employees in 
high-reliability organizations 
sample mean for the PPE-use 
score was 2.4 (SD=1) out of a 




Other limitations included a 
varying number of 
respondents per practice (1-
12 nurses) and missing data.   
Roughly a third of practices 
had only one nurse informant. 
These limitations are 
somewhat offset by the large 
sample size, high response, 
rate, and geographic 
diversity. 
less favorable manager 
leadership and support and 
higher workloads. 
 
Conclusion: Drug spills occur 
in ambulatory settings. PPE 
use remains low, and barriers 
to PPE use persist. Higher 
workloads are associated with 
more drug spills. As nursing 
workloads increased by one 
patient, the odds of HD spills 
increased by 3% (OR=1.03, 
95% CI [1.01-1.06], p=0.01). 
 
Implications for Nursing: 
Managers should monitor and 
correct aberrant workloads 
and ensure that PPE is 
available and that staff are 
trained. 
 
Other Data of Interest: 
The study findings 
underscore the need to 
improve individual adherence 
through modifiable 
administrative controls (e.g., 
commitments to safety 
culture, improved nurse 
practice environments, 
thoughtful attention to nurse 
workloads, deployment of 
engineering controls). 
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Hennessy & 
Dynan (2014)  
Framework for the Model for 
Improvement (Langley, 
Moen, Nolan, Norman, & 
Provost, 1996), a continuous 
process of tests of change, 
performance measurement, 
and feedback was put into 
place to improve 
performance. 
Monthly audits with PPE 
Observation Tool created by 
Dana Farber educators. 
Setting: Dana Farber Cancer 
Institute 
Sample: Infusion nurses in 
ambulatory care 
Time Frame: 2009-2014 
Results: Previous compliance 
rates 30%-40%  
Key components of the 
sustained success of this 
initiative are staff education 
and ownership of the required 
changes, peer-performance 
monitoring, leadership 
support and prioritization of 
the work, staff involvement in 
product review and selection 
of the PPE, and continuous 






A program was developed 
that incorporated not only 
monitoring and reporting 
compliance of the use of PPE, 
but also engaged the staff in 
audit and reporting activities. 
Compliance rates improved 
dramatically over time and 
have remained at high levels. 
 
The goal was to improve 
compliance with established 
standards and hospital policy 
regarding PPE use by nurses 
administering chemo in the 
outpatient setting. 
Hon et al. 
(2014)    
 




spectrometry.   
Active recruitment of 
participants via letter of 
invitation or telephone by 
members of research team. 
On-site surveys and self-
administration questionnaire. 
Setting: 5 hospitals and 1 
cancer treatment facility 
Sample: 115 participants/110 
supplied duplicate hand wipe 
sampling. Staff working in 
the process of flow of drug 
within a facility from initial 
delivery to waste disposal 
(8 groups of workers 
identified). 
Time Frame: not stated 
Results: 225 wipe 
samples/20% (n=44) were 
above the limit of detection 
(LOD) of 0.36ng per wipe. 





Unable to recruit 
housekeepers into study 
because the contract company 
that employs housekeepers 
declined to participate. 
The findings are only 
representative of the point in 
time when samples were 
collected. 
 
Samples were based on 
convenience sampling, which 
allowed assessment of 
The purpose of the study was 
to determine the dermal 
contamination levels of 
healthcare employees 
working throughout the 
hospital and to identify 
factors that may influence 
dermal contamination. 
 
All worker categories had 
some level of dermal 
exposure. Highest level of 
dermal exposure was in 
administration units who 
were not responsible for drug 
administration (volunteers, 
oncologist, aide, dietician). 
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wipe 22.8ng per wipe. (SD 
1.98).  
exposure throughout the day, 
but does not allow 
comparison to task-based 
exposure levels. 
Regardless of whether or not 
a worker received safe drug 
handling training, the 
proportion of samples above 
LOD was the same. 
Kang et al. 
(2017)    
 
Observational, descriptive 
study in 4 parts: a simulation 
observation, a survey (for 
both clinical and sim 
participants), and a follow-up 
evaluation simulation. 
Setting: University of 
Pittsburgh 
Sample: 82 HCP, 65 HCP 
(72.93%; including 3 HCP 
who participated in the 
clinical observation). 97% 
had at least 1 instance of 
contamination during the PPE 
doffing process in 2 sim 
sessions with a simple set and 
a full-body set. For 130 
simulations, the 
contamination rate was 79% 
(n=103) 







High likelihood of Hawthorne 
effect. Because convenience 
sample of study participants 
and PPE items from one 
health care system were 
adopted, these findings may 
not be generalizable to other 
clinical settings. 
Camera lens and lighting may 




Very little is known about 
how healthcare personnel 
actually use PPE. 
Evidence shows that 
traditional learning methods 
(e.g., watching educational 
videos, learning PPE 
guidelines) are inferior to 
immersive learning methods, 
including active learner 
involvement using 
simulations that include 
feedback on performance. 
Contamination breaches 
appear to be associated with 
poor HCP PPE techniques, 
knowledge deficits, and 
behavior flaws. 
The study emphasized the 
need for refining PPE 
protocols based on further 
scientific evidence, 
reinforcing PPE training 
using innovative methods, 
improving and standardizing 
PPE equipment for targeting 
HCP optimal use. 
Lawson et al. 
(2019)    
 
Self-report questionnaire for 
pregnant nurses (within first 
20 weeks) and non-pregnant 
Setting: Online study 
Sample: 40,000 nurses 





The purpose of the study 
assessed glove and gown use 
by female pregnant and non-
pregnant nurses who 
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nurses (within the last 
month). 
Baseline NHS3 questionnaire. 
Health Study born on or after 
January. 1, 1965  
Time Frame: Started in 2010 
and is ongoing 
Results:  
12% of non-pregnant 
nurses/9% pregnant nurses 
indicated they never wore 
gloves with HD admin, 
42%/38% never used a gown, 
32% who crushed HD pills 
did not wear gloves. 
Mean age/non-pregnant = 37 
years (SD 7.26) 
Mean age/pregnant = 29.5 
years (SD 4.05).  
Did not collect info on the use 
of double versus single 
gloves, engineering controls, 
training of safe-handling 
practices, and reasons or 
barriers for not following 
safe-handling 
recommendations. 
No information on nurse 
specialties of respondents. 
No info on facility type or 
size, which might affect 
training personnel. 
administer antineoplastic 
drugs in the U.S. and Canada. 
 
Findings underscore the need 
for further training and 
education to ensure that both 
employers and nurses 
understand the risks involved 
and know which precautions 
will minimize such 
exposures. Adequate time 
must be allowed for worker to 
handle these drugs safely. 
Yuki et al. 
(2013) 
 
Urine and wipe samples from 
patient and family members 
inside homes. 
Gas chromatography in 
tandem with mass 
spectroscopy-mass 




Setting: 3 patient homes 
Sample: 
Time Frame: 
Results: 35 and 16 urine 
samples were collected from 
the three patients and their 
family members. Drugs were 
detected in all samples.  
Cyclophosphamide (CP) in 8 
of 12 samples 5-FU exposure 





Sample size small 
Purpose: To measure the 
urinary excretion of Ads of 
three patients during 48 h 
after the admin of 
cyclophosphamide (2 
patients) and 5-FU (2 
patients) 
 
Home exposure was 
demonstrated. Findings 
indicate the importance of 
strict precautions by the 
members of treated cancer 
patients, as well as healthcare 
workers, to reduce exposure 
to Ads. 
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Appendix B 
IRB from Site 
 
USP <800> AND THE PPE PROJECT   56 
 
Appendix C 
Letter of Approval from Immersion Site 
 




1.  Nurses had no knowledge of the new USP <800> standards for healthcare 
organizations and the PPE mandates for hazardous drug handling and administration. 
2. Most nurses were oncology-certified RNs and understood the need for wearing PPE, 
but did not feel the urgency of self-protection. 
3.  Current RN staffing levels for chemotherapy administration for a 10-hour shift was 
one RN per 10 to 12 patients, which should have been six to eight patients only. 
4. Current patient acuity levels for one RN scheduled for 10 hours was between 20 to 25 
points (points assigned per therapy) instead of 15 to 20 points on average. 
5. The PPE stored on the unit was suboptimal and dependent upon staff calling central 
supply to restock items. 
6. The compliance level for donning PPE was less than 10% prior to the implementation 
of the quality improvement project. 
7. The structural design of the infusion center limited the ability for easy access to PPE in 
all chemotherapy treatment areas. 
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Appendix F 
Work Breakdown Structure 



































1.1 Initiation 1.1.1 Evaluation and Recommendations 
1.1.2 Develop Project Charter 
1.1.3 Deliverable: Submit Project Charter 
1.1.4 USP<800> Committee Reviews Project Charter 
1.1.5 Project Charter Signed/Approved 
1.2 Planning 1.2.1 Create Preliminary Scope Statement 
1.2.2 Determine Project Team 
1.2.3 Project Team Kickoff Meeting 
1.2.4 Develop Project Plan 
1.2.5 Submit Project Plan 
1.2.6 Milestone: Project Plan Approval 
1.3 Execution 1.3.1 Project Kickoff Meeting 
1.3.2 Verify & Validate USP <800> PPE Requirements 
1.3.3 Develop/Organize HD PPE Toolkit 
1.3.4 Decide on Specific Type/Amount of PPE per unit 
1.3.5 Testing Phase in Ambulatory Infusion Center 
         (AIC) 
1.3.6 Completed Toolkit Introduced in AIC 
1.3.7 Staff Training 
1.3.8 Go Live 
1.4 Control 1.4.1 Project Management 
1.4.2 Project Status Meetings 
1.4.3 Risk Management 
1.4.4 Update Project Management Plan 
1.5 Close-out 1.5.1 Audit Procurement 
1.5.2 Document Lessons Learned 
1.5.3 Update Files/Records 
1.5.4 Gain Formal Acceptance 
1.5.5 Archive Files/Documents 
 








Element Name Definition 
1 1 Personal Protective Equipment 
(PPE) Toolkit Implementation in 
Ambulatory Care 
All work to implement the new toolkit in 
Ambulatory Care Setting. 
2 1.1 Initiation The work to initiate the project. 
3 1.1.1 Evaluation and Recommendations Working group to evaluate USP <800> 
General Chapter PPE requirements and 
make recommendations for the 
Ambulatory Care Setting. 
3 1.1.2 Develop Project Charter Project Manager to develop the Project 
Charter. 
3 1.1.3 Deliverable: Submit Project 
Charter 
Project Charter is delivered to USP 
<800> Committee designee. 
3 1.1.4 USP <800> Committee Reviews 
Project Charter 
USP <800> Committee Reviews Project 
Charter. 
3 1.1.5 Project Charter Signed/Approved The USP <800> Committee signs the 
Project Charter which authorizes the 
Project Manager to move to the Planning 
Process. 
2 1.2 Planning The work for the planning process for the 
project. 
3 1.2.1 Create Preliminary Scope 
Statement 
Project Manager creates a Preliminary 
Scope Statement. 
3 1.2.2 Determine Project Team The Project Manager determines the 
project team and requests the resources. 
3 1.2.3 Project Kickoff Meeting The planning process is officially started 
with a project kickoff meeting which 
includes the Project Manager, Project 
Team and USP <800> Committee 
designee. 
3 1.2.4 Develop Project Plan Under the direction of the Project 
manager, the team develops the project 
plan. 
3 1.2.5 Submit Project Plan Project Manager submits the project plan 
for approval. 
3 1.2.6 Milestone: Project Plan Approval The project plan is approved and the 
Project Manager has permission to 
proceed to execute the project according 
to the project plan. 
2 1.3 Execution Work involved to execute the project. 
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3 1.3.1 Project Kickoff Meeting Project Manager conducts a formal 
kickoff meeting with the project team, 
project stakeholders, and USP <800> 
Committee designee. 
3 1.3.2 Verify & Validate USP<800> 
PPE Requirements 
The original USP<800> General Chapter 
requirements for personal protective 
equipment (PPE) use with hazardous 
drug agents is reviewed by the Project 
Manager and team, then validated with 
the stakeholders. This is where additional 
clarification may be needed. 
3 1.3.3 Develop/Organize HD PPE 
Toolkit 
The resources to design the new PPE 
toolkit will be assembled. 
3 1.3.4 Decide on Specific Type/Amount 
of PPE per Unit 
The procurement of all PPE required for 
the project. 
3 1.3.5 Testing Phase in Ambulatory 
Infusion Center 
Team creates a system for testing PPE 
adherence and customizations of user 
interfaces (Low, Moderate, High Risk) 
with hazardous drug handling. 
3 1.3.6 Completed PPE Toolkit 
introduced into Ambulatory 
Infusion Center setting 
The actual PPE Toolkit is introduced into 
the Ambulatory Infusion Center’s 
workflow processes. 
3 1.3.7 Staff Training All staff are provided with a one-hour 
training on donning and doffing of PPE. 
Additionally, managers are provided 
with a two-hour class to cover advanced 
reporting. 
3 1.3.8 Go Live System goes live with all Ambulatory 
Infusion Center (AIC) staff. 
2 1.4 Control  The work involved for the control 
process of the project. 
3 1.4.1 Project Management Overall project management for the 
project. 
3 1.4.2 Project Status Meetings Weekly team status meetings. 
3 1.4.3 Risk Management Risk management efforts as defined in 
the Risk Management Plan. 
3 1.4.4 Update Project Management Plan Project Manager updates the Project 
Management Plan as the project 
progresses. 
2 1.5 Close-out The work to close out the project. 
3 1.5.1 Audit Procurement An audit of all measurement tools and 
management plans procured for the 
project, ensure that all procured products 
are accounted for and in the asset 
management system. 
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3 1.5.2 Document Lessons Learned Project Manager along with the project 
team performs a “lessons learned” 
meeting and documents the lessons 
learned from the project. 
3 1.5.3 Update Files/Records All files, data, and adherence monitoring 
tools are updated to reflect the completed 
PPE Toolkit intervention. 
3 1.5.4 Gain Formal Acceptance The USP <800> Committee formally 
accepts the project by signing the 
acceptance document included in the 
project plan. 
3 1.5.5 Archive Files/Documents All project related files and documents 
are formally archived. 
 








Ambulatory Care refers to medical services performed on an outpatient 
basis, without admission to a hospital or other facility. Ambulatory care is 
provided in settings such as dialysis clinics, ambulatory infusion centers, 
ambulatory surgical centers, hospital outpatient departments, and the 
offices of physicians and other health professionals. 
Hazardous Drug 
Agents (HDs) 
In pharmacology, hazardous drugs are drugs that are known to cause 
harm, which may or may not include genotoxicity (the ability to cause a 
change or mutation in genetic material). These drugs can be classified as 
antineoplastic, cytotoxic agents, biologic agents, antiviral agents and 
immunosuppressive agents. The NIOSH criteria include: carcinogenicity, 
teratogenicity, reproductive toxicity, genotoxicity, organ toxicity at low 
doses, and drugs that mimic existing drugs in structure or toxicity. 





Personal protective equipment is protective clothing, headwear, goggles, 
gloves, shoe covers, respirators, or other garments or equipment designed 
to protect the wearer’s body from injury, infection, or exposure to 
hazardous agents. The hazards addressed by protective equipment include 
physical, electrical, heat, chemicals, biohazards, and airborne particulate 
matter. 
PPE Toolkit A set of resources, interventions, and skills required to ensure staff 
adherence to hazardous drug safe handling and compliance with USP 
General Chapter <800> requirements for PPE selection and use during 





Protects any worker in contact with hazardous drugs or the patient 
environment and includes, but not limited to; pharmacists; technicians, 
nurses, physicians, physician assistants, nurse practitioners, home health 
care, environmental services workers, engineering, anyone entering a 
patient treatment area, pharmacies, hospitals, and other healthcare 
institutions, patient treatment clinics, physician practices, and the public. 
WBS Code A unique identifier assigned to each element in a Work Breakdown 
Structure for the purpose of designating the elements hierarchical location 
within the WBS. 
WBS 
Component 
A component of a WBS which is located at any level.  It can be a Work 
Package or a WBS Element as there’s no restriction on what a WBS 
Component is. 
WBS Element A WBS element is a single WBS component and its associated attributes 
located anywhere within a WBS. A WBS Element can contain work, or it 
can contain other WBS Elements or Work Packages. 
Work Package A Work Package is a deliverable or work component at the lowest level of 
its WBS branch. 
 
 





•  Expert Oncology Staff Resources 
•  Infusion-Trained/Chemotherapy certified RN 
Team 
•   Supportive Executive Leadership/Management 
Teams 
•  Long-term Employees at the Facility committed 
to quality improvement at all levels 
•  Teamwork between various 
divisions/pharmacy/physician offices and 





•  Room design and waste management not 
practical for effective safe handling. 
•  Employee and environmental surveillance 
inconsistently performed and costly. 
•  Policies and Procedures (P&P) reflect guidance 
for PPE use, not mandatory (open to interpretation 
by staff nurses) 
•  Unknown cost impact for meeting the USP 
<800> Standards for PPE use. 
•  No system-defined comprehensive list of HDs, 
and no risk assessment for all HDs. 
•  No Standard Work process for PPE utilization 
with HD administration 
•  Beliefs and attitudes of nurses that PPE is a 
personal choice.  
•  No audit tools to ensure compliance with USP 
<800> Standards for PPE use. 
Opportunities 
•  Increase in demand for ambulatory infusion 
services across the country requires more 
oncology-infusion trained nurses/may need to 
partner with nursing schools to provide 
exposure/hiring pool for future needs. 
•  Decrease the gap between leadership and 
frontline infusion nurses to improve care delivery 
and patient/nurse safety in the AIC 
•  Increase in the aging population with baby 
boomers at Medicare age 
•  Increase all infusion nurses training on 
chemotherapy/biotherapy/ infusion therapy for 
future growth needs 
Threats 
•  Unknown costs associated with PPE equipment, 
environmental testing for residues, and health 
monitoring of staff for HD exposure/no known 
HD limits like radiation oncology practice. 
•  Maintaining and recruiting nurses to work in 
high risk for exposure environment. 
•  Decrease in funding for infusion services with 
21st Century Cures Act. Political climate related 
to healthcare structural changes within the 
political parties as to what changes will be 
implemented 
•  Deadline extended for implementation of USP 
<800> regulations. 
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Appendix J 
Responsibility / Communication Matrix 
Who What How 
Cancer Committee Members Evaluation and Recommendations Monthly at Cancer Committee meeting 
Assistant Unit Manager (AUM) AIC Develop Project Charter Discuss project with leadership and ask for 
recommendations of persons interested in 
working on the PPE Project Team 
Assistant Unit Manager (AUM) AIC Submit Project Charter Meet with interested people and gain buy-in 
and have them help finalize the Charter and 
AUM will send completed Charter to USP 
<800. Committee 
USP <800> Committee USP <800> Committee Reviews Project 
Charter 
Present at USP <800> Committee meeting 
and request approval from Project Sponsor 
USP <800> Committee/Cancer Committee Project Charter Approved Committee will approve Charter and report 
back to DNP team 
Cancer Committee 
NPs/Pharmacy/AUM/Clinical Nurse Educator 
Create Preliminary Scope Statement Meeting with the group to discuss the needs 
of the Cancer Center related to physician 
practices/specialties 
Assistant Unit Manager Determine Project Team AUM to meet with interested persons and 
select based on knowledge and skills related 
to HD management and PPE knowledge 
Project Charter Team Members Project Team Kickoff Meeting Arrange for meeting with group once Charter 
has been approved via Skype or Zoom 
sessions 
Assistant Unit Manager (AUM) Submit Project Plan AUM to assist team with project plan and 
submit to USP<800> committee 
Cancer Committee Members/ Executive 
Director Cancer Center 
Milestone: Project Plan Approval Report back to Cancer Committee and gain 
approval at next meeting 
USP <800> PPE Group Project Kickoff Meeting Notify PPE group of plans to set up meeting 
by email and personal telephone calls 
Clinical Nurse Educator 
Pharmacy Department 
USP <800> Committee Representative 
Verify & Validate USP <800> Requirements Check with OSHA, NIOSH, and USP<800> 
Committee to confirm requirements for PPE 
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Clinical Nurse Educator/ DNP Student (AUM 
in AIC) 
Develop/Organize HD PPE Toolkit Review current evidence regarding toolkit 
resources for HD PPE/select tools/request 
permission from owners of tools to use 
Clinical Nurse Educator/ DNP Student 
Relief Charge Nurses in AIC/Central Supply 
Department 
Decide on Specific Type/Amount of PPE per 
unit 
Request items used for PPE and bring to unit 
for evaluation by nurses/discuss preferences 
and select type and amount needed for test 
phase 
Clinical Nurse Educator/DNP Student Testing Phase in AIC Preliminary testing with one RC to determine 
feasibility of project and to demonstrate 
“Observation of PPE Tool” purpose and 
planned confidential use 
NPs, Pharmacist, AUM Confidential Observations in AIC Audits over 2 weeks at random intervals by 
practitioners, pharmacy, and AUM during 
routine rounding in AIC 
Oncology MD, NPs, Pharmacist, OCN Nurse, 
Oncology Nurse Educator, AUM 
Educational Intervention by Panel Select panel of experts to introduce HD 
education and need for PPE/invite to 
informational meeting about project 
DNP Student/ Clinical Nurse Educator Completed Toolkit introduced in AIC Review final Tools for the toolkit and get 
approval from Executive Director and expert 
panel members to proceed with 
printing/preparing for intervention 
RN Staff in AIC Staff Training-Peer-to-Peer Review Provide inservice during monthly staff 
meeting to teach use of peer-to-peer review 
tool for PPE during administration 
All Staff in AIC Go Live Use huddle boards, email, and text reminders 
of Go Live with PPE date 
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Appendix K 
Cost Benefit Analysis 
Cost Benefit Analysis 
Implementation of HD Safe-Handling Toolkit 
Initial Implementation/Year 1/ 2020 
Total Cost = $28, 950 
Cost Avoidance x 1 year related to Workers Compensation Claims for Exposure x 1 nurse = 
$37,540 
Savings Year 1 = $8, 590 
 




Type of Expense Cost 
Staff Training on “Observation of PPE Use” Tool (NP, 
CNL, Clinical Nurse Educator, Pharmacist) – 1 hour 
Discussion  
$75/hr. x 7 = $525 
Staff Training on “Hazardous Drug Administration Safe-
Handling Checklist” Tool (1 Clinical Nurse Educator, 2 
Relief Charge Nurse, 2 Pediatric Infusion Nurses, 2 
Nurse Practitioners) 
$75/hr. x 7 = $525 
Expert Panel Discussion for All Staff Nurses Complimentary Time from Cancer 
Committee Budget $1200 
Staff Training estimate based on $75/hr. (15 nurses) 1 
hour training during staff meeting 
$1,125 
USP <800> Compliance: Hazardous Drug 
Administration Toolkit for Infusion Nurses (Printing) 
$1,000 
PPE Supplies including White Preparation Trays in 
Medication Rooms 
Average 5 RNs per day x 10 hrs. = 50 hours, Average 
nurse # PPE changes per patient (5) x 15 PPE changes 
per day  
$15 per PPE Kit x 15 changes/per 
nurse/per shift = $210 
x 5 nurses/per day =$1,050 per day x 7 
days/week = $7350 per week 
Hazardous Waste Bins for PPE and Medical Waste per 
cubicle (35) 
$35/waste bin x 35 cubicles = $1225 
per week 
DNP Student/Assistant Unit Manager salary and time 215 hours at $80.00/hr. = $17,200 
Estimated Total $28,950 + ($1200 in kind) 
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Appendix M 









Over Three Years Average Claim 
$37,540 $370,540 $1.1 million 
   
 (WCIRB, 2017) 
Information based on the average California indemnity claim report for 2017 (Note: The average 
claim in California is 40% higher than the median average nationwide and paid over three years.) 
 
The return on investment is clear. Nurses who have been exposed to hazardous drug residues 
may develop adverse health issues for many years and may require long-term follow-up to 
manage the consequences of exposure. A program that instills the importance of an HD exposure 
prevention strategy at a nominal cost is worth saving millions of dollars and minimizing the risk 
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Appendix N 
USF QI Approval 
On File with the University of San Francisco 
 
 






Demographic M SD 
Age (years) 44 14.0 
Experience   
   Nursing 19 13.4 
   Oncology 14 10.1 
Treatment volume  M Mdn 
   Patients per day 10 10 
Education % N 
   Diploma 0 0 
   Associate’s degree 10 1 
   Bachelor’s degree 70 7 
   Master’s degree 20 2 
Note. Mdn = median, SD = standard deviation, N = number of nurses. 
Note. Fifteen surveys distributed, 10 RNs eligible, 3 RNs ineligible (< 2 years oncology experience), 1 RN on 
maternity leave, 1 RN retired. 
 





Nurses’ Self-Assessment of Adherence to PPE Use Results Summary (N = 10) 
 
Question Never Rarely Sometimes Usually Always 
% n % n % n % n % n 
Q1: Uses absorbent pad on work surface for chemotherapy agents. 20 2 0 0 20 2 10 1 50 5 
Q2: Wears one pair of chemotherapy-approved gloves to remove 
chemotherapy agents from transport bag. 
20 2 0 0 0 0 20 2 60 6 
Q3: Wears two pairs of chemotherapy-approved gloves to remove 
chemotherapy agents from transport bag. 
50 5 0 0 0 0 30 3 20 2 
Q4: Removes outer gloves prior to programming pump. 20 2 10 1 20 2 30 3 20 2 
Q5: Washes hands after removing gloves. 0 0 0 0 0 0 30 3 70 7 
Q6: Wears second pair of chemotherapy-approved gloves over 
ribbed cuff of gown. 
30 3 30 3 0 0 10 1 30 3 
Q7: Removes gown prior to leaving room. 0 0 0 0 30 3 30 3 40 4 
Q8: Wears chemotherapy-approved gown, with first pair of 
approved gloves under ribbed cuff. 
20 2 0 0 0 0 30 3 50 5 
Q9: Disposes of gloves in a chemotherapy-approved container after 
initiating chemotherapy after disconnecting and discarding 
chemotherapy agent. 
0 0 0 0 10 1 10 1 80 8 
Q10: Removes gown prior to leaving room after disconnection and 
discarding chemotherapy. 
0 0 0 0 20 2 20 2 60 6 
Q11: Wears two pairs of chemotherapy-approved gloves and 
chemotherapy-approved gown when handling chemotherapy. 
20 2 30 3 10 1 30 3 10 1 
Q12: Wraps gauze pad around connection site (CSTD) when 
disconnecting chemotherapy tubing, leaving chemotherapy bag 
attached. 
60 6 10 1 20 2 10 1 0 0 
Q13: Disposes of gloves in a chemotherapy-approved container. 0 0 0 0 0 0 10 1 90 9 
Q14: Washes hands after disposal of gloves in the chemotherapy-
approved container. 
0 0 0 0 10 1 20 2 70 7 
Q15: Discards the chemotherapy bag and attached secondary 
tubing in chemotherapy-approved waste container. 
0 0 0 0 0 0 0 0 100 10 
 




Observations of Chemotherapy Safe-Handling Adherence in Number of Events (N = 50) 
 
Behavior Adherence (n) Observation (n) 
Handling and Administration   
1. Uses absorbent pad on work surface for chemotherapy 
agents. 
16 50 
2. Wears one pair of chemotherapy-approved gloves to 
remove chemotherapy agent from transport bag. 
33 50 
3. Wears two pairs of chemotherapy-approved gloves to 
remove chemotherapy agents from transport bag. 
24 50 
4. Removes outer gloves prior to programming pump. 14 50 
5. Washes hands. 36 50 
6. Wears second pair of chemotherapy-approved gloves over 
ribbed cuff of gown. 
19 50 
7. Removes gown prior to leaving room. 40 50 
8. Wears chemotherapy-approved gown, with first pair of 
chemotherapy-approved gloves under ribbed cuff of gown. 
40 50 
9. Disposes of gloves in a chemotherapy-approved container 
after initiating chemotherapy. 
42 50 
Disconnecting and Discarding   
1. Removes gown prior to leaving room. 44 50 
2. Wears two pairs of chemotherapy-approved gloves and 
chemotherapy-approved gown when handling 
chemotherapy. 
16 50 
3. Wraps gauze pad around connection site (CSTD) when 
disconnecting chemotherapy tubing, leaving chemotherapy 
bag attached. 
4 50 
4. Disposes of gloves in a chemotherapy-approved container. 44 50 
5. Washes hands. 36 50 
6. Discards the chemotherapy bag and attached secondary 
tubing in chemotherapy-approved waste container. 
46 50 
 

















(N = 50 number 
of events) 
% 
Handling and Administration   
1. Uses absorbent pad on work surface for chemotherapy 
agents. 
50 32 
2. Wears one pair of chemotherapy-approved gloves to 
remove chemotherapy agent from transport bag. 
60 66 
3. Wears two pairs of chemotherapy-approved gloves to 
remove chemotherapy agents from transport bag. 
20 48 
4. Removes outer gloves prior to programming pump. 20 28 
5. Washes hands. 70 72 
6. Wears second pair of chemotherapy-approved gloves over 
ribbed cuff of gown. 
30 38 
7. Removes gown prior to leaving room. 40 80 
8. Wears chemotherapy-approved gown, with first pair of 
chemotherapy-approved gloves under ribbed cuff of gown. 
50 80 
9. Disposes of gloves in a chemotherapy-approved container 
after initiating chemotherapy. 
80 84 
Disconnecting and Discarding   
1. Removes gown prior to leaving room. 50 88 
2. Wears two pairs of chemotherapy-approved gloves and 
chemotherapy-approved gown when handling 
chemotherapy. 
10 32 
3. Wraps gauze pad around connection site (CSTD) when 
disconnecting chemotherapy tubing, leaving chemotherapy 
bag attached. 
0 8 
4. Disposes of gloves in a chemotherapy-approved container. 90 88 
5. Washes hands. 70 72 
6. Discards the chemotherapy bag and attached secondary 
tubing in chemotherapy-approved waste container. 
100 92 
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Appendix Q 
Proposed CQI Method and Data Collection 
Variable Name Brief Description Data 
Source 





of Adherence to 
PPE use 
Nurses evaluate their own 
personal competency skills 
with adherence and 




Table 1: Sample 
Characteristics 
Table 2:  Nurses’ Self-
assessment of Adherence to 
PPE Use (Hennessey & 
Dynan, 2014) 
15-item questionnaire that uses a 
five-point Likert-type response 
set ranging from 0 (never) to 4 





Assessment for Adherence 
by trained observers 
Tool Table 3: Observations of 
Chemotherapy Safe-Handling 
Adherence in Number of 
Events 
(Colvin, Karius, & Albert, 
2016) 





Comparison Summary Tool Table 4. Differences between 
Nurses’ Self-Assessment of 
Adherence from Survey and 
Direct Observation of 
Adherence 
Percentage totals N/A 
Behavior Project Data Collection 
Tool to compare 
Observation Adherence to 
Self-Assessment 
Adherence 















Tool Table 6: PPE Observation 
Tool for Compliance with 
Hospital Hazardous Drug 
(HD) Safe-Handling Policy 
Medians and Quartiles of counts 
and percentages 
Two Weeks 
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Appendix R 
Hazardous Drug Administration Safe-Handling Checklist (Peer-to-Peer Feedback Tool) 
Nurse’s Initial:                                       Date of Review:                              Pt. MR#:  
PRIOR TO ADMINISTRATION Yes No Initials 
1. Gather equipment required for drug administration.    
2. Select appropriate gloves for hazardous drug administration.    
3. Select appropriate gown for hazardous drug administration.    
4. Identify situations when mask and face protection are required.    
5. Locate hazardous drug spill kit.    
6. Obtain hazardous waste container.    
ADMINISTRATION    
1. Wash hands and don personal protective equipment (PPE) before opening 
drug delivery bag. 
   
2. Visually inspect the contents of the delivery bag for leaks.    
3. Gather IV administration supplies including closed-system drug-transfer 
devices (CSTD). 
   
4. For IV infusions: 
• Ensure tubing is primed with a nondrug solution. 
• Utilize plastic backed absorbent pad under work areas.  Remove cap 
from IV tubing and connect to patient’s IV device. 
   
   
• Utilize closed-system drug-transfer device when compatible.    
• Tighten locking connections. 
• When complete, don PPE and discontinue IV bag with tubing intact 
(do not unspike bag). 
• Utilize gauze pads when disconnecting from patient’s IV device when 
a closed-system drug-transfer device cannot be used. 
   
   
   
5. For IV Push Medications 
• Utilize closed-system transfer device when possible. 
   
• Tighten locking connection.    
• When complete, do not recap needle. 
• Discard syringe-needle unit in puncture-proof container. 
   
POST-ADMINISTRATION    
1. Don personal protective equipment.    
2. Seal hazardous drug-contaminated supplies in sealable plastic bag for 
transport to hazardous waste container. 
   
3. Place sealed plastic bag in hazardous waste container.    
4. Remove outer gloves.    
5. Close lid on waste container.    
6. Decontaminate equipment in the area appropriately.    
7. Remove and discard inner gloves.    
8. Wash hands thoroughly with soap and water.    
Reviewer Signature: _____________________________________Initials: _______________ 
Comments:  
USP <800> AND THE PPE PROJECT   98 
 
Appendix S 
PPE Observation Tool 
For each observation, indicate “yes” for compliant with safe-handling policy or “no” if not compliant. If 
“no”, check the corresponding box for a description of the failure to comply. More than one description 
may apply to one observation (Hennessey & Dynan, 2014). 














































Observation: Compliant with USP 
<800> Hospital Policy  
 Observation type (checkbox)            
          
Pre-Administration 
• Handling bags or syringes 
outside the leak-proof 
transport bag requires gloves 
and gowns. 
• Handling the closed, zipped 
leak-proof bag does not 
require gown (gloves are 
optional). 
          
Administration 
• Hanging, bags, attaching 
tubing, administering IVP, IM, 
SC requires gloves and gown. 
 
          
Discard 
• Take down of bags and tubing 
that contain or contained 
chemotherapy and discarding 
syringes after IVP, IM, and 
SC requires gown and gloves,  
          
Description of Non-Compliance           
• Wore no gloves           
• Wore no chemotherapy gloves           
• Wore non-chemotherapy 
gloves 
          
• Wore no gown           
• Reused gown           
• PPE gown worn in non-patient 
care area 
          
• Chemotherapy at desk or in 
the non-patient care area 
          
Additional Comments: 
Observation #  
          
IM - Intramuscular; IVP - Intravenous Push; PPE - personal protective equipment; SC - subcutaneous 
